Free Trial
NASDAQ:HUMAW

Humacyte (HUMAW) Stock Price, News & Analysis

Humacyte logo
$0.30 +0.03 (+9.09%)
As of 05/9/2025 12:08 PM Eastern

About Humacyte Stock (NASDAQ:HUMAW)

Key Stats

Today's Range
$0.30
$0.30
50-Day Range
$0.24
$1.03
52-Week Range
$0.17
$3.47
Volume
205 shs
Average Volume
31,514 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Receive HUMAW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Humacyte and its competitors with MarketBeat's FREE daily newsletter.

HUMAW Stock News Headlines

Humacyte (NASDAQ:HUMAW) Trading Down 2% - Should You Sell?
See More Headlines

HUMAW Stock Analysis - Frequently Asked Questions

Humacyte's stock was trading at $1.82 on January 1st, 2025. Since then, HUMAW shares have decreased by 83.5% and is now trading at $0.30.
View the best growth stocks for 2025 here
.

Shares of HUMAW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HUMAW
Fax
N/A
Employees
150
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:HUMAW) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners